Trials / Conditions / Recurrent Nasopharynx Carcinoma

Recurrent Nasopharynx Carcinoma

7 registered clinical trials studyying Recurrent Nasopharynx Carcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Re NCT07332247	Sun Yat-sen University	Phase 2
Recruiting	EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma NCT06802835	Sun Yat-Sen University Cancer Center	Phase 1 / Phase 2
Terminated	BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer NCT02706691	University of Chicago	Phase 2
Active Not Recruiting	Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513	M.D. Anderson Cancer Center	Phase 2
Completed	Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivar NCT02538510	University of Washington	Phase 1 / Phase 2
Completed	Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer NCT02339558	National Cancer Institute (NCI)	Phase 2
Terminated	Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma NCT02137096	University of Florida	Phase 3